Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open Label Phase I Trial of PBI-05204 in Advanced Cancer Patients.

Trial Profile

An Open Label Phase I Trial of PBI-05204 in Advanced Cancer Patients.

Phase of Trial: Phase I

Latest Information Update: 13 Jun 2014

At a glance

  • Drugs PBI 05204 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 07 Jun 2011 Status changed from active, no longer recruiting to completed, final results have been reported at ASCO 2011.
    • 07 Jun 2011 Final results have been reported in an abstract under the Poster Discussion Session, Developmental Therapeutics - Experimental Therapeutics at ASCO 2011.
    • 24 May 2011 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top